August 19, 2017 9:30 AM ET


Company Overview of MannKind Corporation

Executive Profile

Michael A. Friedman M.D.

AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 8 different industries.

See Board Relationships


Dr. Michael A. Friedman, M.D., served as the Chief Executive Officer of City Of Hope until January 1, 2014. Dr. Friedman served as the Chief Executive Officer of City of Hope National Medical Center until February 2013. He was an Acting Commissioner of the U.S. Food and Drug Administration (FDA), joined City of Hope, located in the Los Angeles area, in May 2003. He served as the President of City Of Hope Inc. Prior to assuming his role at City of Hope, Dr. Friedman served ...

Corporate Headquarters

25134 Rye Canyon Loop
Valencia, California 91355

United States

Phone: 661-775-5300
Fax: --

Board Members Memberships

Independent Director
Independent Non-Executive Director


Post-Doctoral Training
Stanford University
University of Texas Southwestern Medical Center - Dallas
Tulane University
Post-Doctoral Training
Institut National Du Cancer

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$67,500
Total Calculated Compensation$174,516

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Vincent A. Forlenza Chairman and Chief Executive Officer
Becton, Dickinson and Company
Christophe Weber Presidednt, CEO & Representative Director
Takeda Pharmaceutical Company Limited
John E. Timberlake Chief Executive Officer, President and Director
Valeritas Holdings, Inc.
Sophie Baratte MBA, Ph.D.CEO & Director
Cellnovo Limited
Robert T. Brooke CEO, Secretary, Treasurer & Director
Vitality Biopharma, Inc.
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MannKind Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at